![]() |
市场调查报告书
商品编码
1885815
单细胞蛋白水解物市场机会、成长驱动因素、产业趋势分析及预测(2025-2034年)Single-Cell Protein Hydrolysates Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034 |
||||||
2024 年全球单细胞蛋白水解物市值为 2.884 亿美元,预计到 2034 年将以 9.5% 的复合年增长率增长至 7.21 亿美元。

单细胞蛋白(SCP)水解物正成为永续蛋白质经济的关键组成部分,这得益于其优异的消化率、丰富的氨基酸来源以及源自细菌、酵母、真菌和微藻等微生物的功能特性。 SCP的生产环境足迹小,通常利用废弃物或气基原料,使其在动物营养、人类食品和营养保健品领域极具吸引力。随着全球蛋白质需求的成长和环境压力的加剧,SCP水解物在水产养殖饲料、临床营养和循环生物经济策略中日益受到重视。 SCP水解物与循环系统的契合,特别是利用工业废气、有机残渣和生物质衍生底物,有助于解决土地资源限制、减少排放和保障粮食安全等问题。这些因素正推动SCP水解物从新兴技术走向广泛应用的商业解决方案。
| 市场范围 | |
|---|---|
| 起始年份 | 2024 |
| 预测年份 | 2025-2034 |
| 起始值 | 2.884亿美元 |
| 预测值 | 7.21亿美元 |
| 复合年增长率 | 9.5% |
2024年,细菌来源的单细胞蛋白水解物市占率占比达34%,预计到2034年将以8.9%的复合年增长率成长。由于生物质生成速度快、可扩展性强以及与气基底物相容,细菌和酵母平台生产的水解物市场持续成长。它们被用于改善肠道功能,而酵母来源的水解物,特别是来自酿酒酵母属的水解物,在宠物食品和风味增强剂领域也越来越常见。
动物营养领域在2024年占据45.4%的市场份额,预计到2034年将以9.3%的复合年增长率成长。水产养殖业是成长的主要驱动力,这得益于单细胞蛋白(SCP)原料的稳定性和易消化性,为传统的海洋蛋白提供了一种可持续的替代方案。微生物蛋白供应商正在为不同物种量身定制解决方案,宠物食品行业的製造商正在添加酵母和细菌水解物以改善适口性和促进消化健康。畜牧业也在采用单细胞蛋白水解物来降低饲料成本并减少对传统添加剂的依赖。
2024年美国单细胞蛋白水解物市场规模达7,030万美元,预计2025年至2034年将以9.5%的复合年增长率成长。随着许多创新者利用天然气和工业副产品扩大单细胞蛋白水解物的生产,美国仍是饲料和营养应用领域规模化和技术进步的关键驱动力。
全球单细胞蛋白水解物市场的主要参与者包括Calysta、Unibio、Solar Foods、KnipBio、Quorn Foods、Arbiom、Corbion、DSM-Firmenich、Novozymes(现为Novonesis的一部分)、Angel Yeast、Lesaffre、Alltech、Nutreco和AlgaeCytes。这些企业正透过大规模发酵扩张、成本优化的生物加工以及先进的菌株工程来提升蛋白质产量和改善营养成分,从而巩固其市场地位。许多公司正与饲料生产商和食品公司建立供应合作伙伴关係,以确保长期合约,同时根据特定物种的营养需求客製化水解物成分。永续发展承诺,包括使用废弃物衍生原料和气体驱动原料,正帮助企业脱颖而出,成为环保供应商。产品多元化、合规策略以及对临床营养和功能性配方等高价值应用领域的投资,进一步巩固了企业在全球市场的领先地位。
The Global Single-Cell Protein Hydrolysates Market was valued at USD 288.4 million in 2024 and is estimated to grow at a CAGR of 9.5% to reach USD 721 million by 2034.

Single-cell protein (SCP) hydrolysates are becoming a crucial component of the sustainable protein economy, supported by their strong digestibility, amino acid availability, and functional attributes derived from microbial sources such as bacteria, yeast, fungi, and microalgae. Their production is associated with a low environmental footprint, often relying on waste streams or gas-based feedstocks, which enhances their appeal across animal nutrition, human food applications, and nutraceuticals. As global protein requirements increase and environmental pressures intensify, SCP hydrolysates are gaining prominence in aquaculture diets, clinical nutrition, and circular bioeconomy strategies. Their alignment with circular systems, especially using industrial off-gases, organic residues, and biomass-derived substrates, helps address land constraints, emission reduction efforts, and food security priorities. These factors are moving SCP hydrolysates from emerging technologies into widely adopted commercial solutions.
| Market Scope | |
|---|---|
| Start Year | 2024 |
| Forecast Year | 2025-2034 |
| Start Value | $288.4 Million |
| Forecast Value | $721 Million |
| CAGR | 9.5% |
The bacterial SCP hydrolysates segment accounted for 34% in 2024 and is expected to grow at a CAGR of 8.9% by 2034. Hydrolysates produced from bacterial and yeast platforms continue to expand due to rapid biomass generation, strong scalability, and compatibility with gas-based substrates. They are used to enhance gut performance, while yeast-derived hydrolysates, particularly from Saccharomyces species, are becoming more common in pet food and flavor-enhancing applications.
The animal nutrition segment held a 45.4% share in 2024 and is projected to grow at a CAGR of 9.3% through 2034. Growth is led by aquaculture, driven by the stability and digestibility of SCP ingredients, offering a sustainable alternative to conventional marine-based proteins. Providers of microbial proteins are customizing solutions for various species, and manufacturers in the pet food sector are incorporating yeast and bacterial hydrolysates to improve palatability and digestive health. Livestock operations are also adopting SCP hydrolysates to lower feed expenses and reduce dependency on traditional additives.
U.S. Single-Cell Protein Hydrolysates Market reached USD 70.3 million in 2024 and is anticipated to register a CAGR of 9.5% from 2025 to 2034. With multiple innovators expanding SCP hydrolysate production using natural gas and industrial co-products, the United States remains a key driver of scale-up and technological advancement across feed and nutrition applications.
Major companies participating in the Global Single-Cell Protein Hydrolysates Market include Calysta, Unibio, Solar Foods, KnipBio, Quorn Foods, Arbiom, Corbion, DSM-Firmenich, Novozymes (now part of Novonesis), Angel Yeast, Lesaffre, Alltech, Nutreco, and AlgaeCytes. Companies competing in this market are strengthening their positions through large-scale fermentation expansion, cost-optimized bioprocessing, and advanced strain engineering to boost protein yields and enhance nutrient profiles. Many firms are forming supply partnerships with feed manufacturers and food companies to secure long-term contracts while tailoring hydrolysate compositions for species-specific nutritional needs. Sustainability commitments, including the use of waste-derived and gas-fed feedstocks, are helping companies stand out as environmentally aligned suppliers. Product diversification, regulatory compliance strategies, and investments in high-value applications such as clinical nutrition and functional formulations are further supporting stronger global market footholds.